Discover a practical trading strategy that combines options and ETFs. Create Your Own Hedge Fund explains how exchange-traded funds can be used in conjunction with an options strategy to attain steady growth. Beginning with a tutorial on options and ETFs, the book goes on to describe both investment approaches in great detail providing you with a trading strategy that generates higher returns than buy-and-hold investing -- and allows you to reduce risk by adopting a hedging strategy. Filled with in-depth insights and expert advice, this book is intended for you if you're a sophisticated individual investor or a professional investor, trader, or other money manager looking to update your arsenal of investment tools. Order your copy today!
Learn to use options from veteran option trader Mark D. Wolfinger, who spent more than 20 years on the floor of the Chicago Board Options Exchange (CBOE). If you are a seasoned stock trader or a casual investor who dabbles in mutual funds, this book is for you.
Iron condor trading has a lot to recommend it because the strategy is easy to understand and the trade can be set up with a high probability of making money. Those are very enticing qualities for traders, especially rookie traders. In Trading CTM (Close to the Money) Options, Wolfinger explains why better results are achieved by trading closer-to-the-money (CTM) iron condors. Discover why it’s actually advantageous to trade with a reduced probability of winning. The combination of larger profits (and smaller losses), coupled with the ease of making risk-reducing adjustments (if needed) make CTM iron condors the winning choice. Read the clear arguments why CTM iron condors come with a built-in trading advantage. Important reminder: No strategy is suitable under all market conditions.
In an era where “buy and hold” investment strategies no longer work, investors desperately need portfolio protection. Fortunately, it’s available—in the form of options. In Why Trade Options? top trader and options instructor Mark D. Wolfinger shows how options can be used conservatively, to systematically reduce risk and protect assets. Wolfinger explains the choices that options provide to cautious investors and explains the tradeoffs associated with each alternative. You’ll learn how to use “protective” (a.k.a. “married”) puts to buy complete protection at a higher price—and how to use covered calls to gain more modest protection, without paying a dime out of pocket. Wolfinger shows how to use simple “collars” to gain more protection at lower cost and helps you use options-based “stock replacement” strategies to lock in stock profits (while objectively considering the tax implications). Nowadays, intelligent investors need to address risk as much as return. Why Trade Options? gives them powerful tools for doing just that.
This is truly an outstanding book. [It] brings together all of the latest research in clinical trials methodology and how it can be applied to drug development.... Chang et al provide applications to industry-supported trials. This will allow statisticians in the industry community to take these methods seriously." Jay Herson, Johns Hopkins University The pharmaceutical industry's approach to drug discovery and development has rapidly transformed in the last decade from the more traditional Research and Development (R & D) approach to a more innovative approach in which strategies are employed to compress and optimize the clinical development plan and associated timelines. However, these strategies are generally being considered on an individual trial basis and not as part of a fully integrated overall development program. Such optimization at the trial level is somewhat near-sighted and does not ensure cost, time, or development efficiency of the overall program. This book seeks to address this imbalance by establishing a statistical framework for overall/global clinical development optimization and providing tactics and techniques to support such optimization, including clinical trial simulations. Provides a statistical framework for achieve global optimization in each phase of the drug development process. Describes specific techniques to support optimization including adaptive designs, precision medicine, survival-endpoints, dose finding and multiple testing. Gives practical approaches to handling missing data in clinical trials using SAS. Looks at key controversial issues from both a clinical and statistical perspective. Presents a generous number of case studies from multiple therapeutic areas that help motivate and illustrate the statistical methods introduced in the book. Puts great emphasis on software implementation of the statistical methods with multiple examples of software code (both SAS and R). It is important for statisticians to possess a deep knowledge of the drug development process beyond statistical considerations. For these reasons, this book incorporates both statistical and "clinical/medical" perspectives.
Classic biostatistics, a branch of statistical science, has as its main focus the applications of statistics in public health, the life sciences, and the pharmaceutical industry. Modern biostatistics, beyond just a simple application of statistics, is a confluence of statistics and knowledge of multiple intertwined fields. The application demands, the advancements in computer technology, and the rapid growth of life science data (e.g., genomics data) have promoted the formation of modern biostatistics. There are at least three characteristics of modern biostatistics: (1) in-depth engagement in the application fields that require penetration of knowledge across several fields, (2) high-level complexity of data because they are longitudinal, incomplete, or latent because they are heterogeneous due to a mixture of data or experiment types, because of high-dimensionality, which may make meaningful reduction impossible, or because of extremely small or large size; and (3) dynamics, the speed of development in methodology and analyses, has to match the fast growth of data with a constantly changing face. This book is written for researchers, biostatisticians/statisticians, and scientists who are interested in quantitative analyses. The goal is to introduce modern methods in biostatistics and help researchers and students quickly grasp key concepts and methods. Many methods can solve the same problem and many problems can be solved by the same method, which becomes apparent when those topics are discussed in this single volume.
The need to understand and predict the processes that influence the Earth's atmosphere is one of the grand scientific challenges for the next century. This volume is a series of case studies and review chapters that cover many of the recent developments in statistical methodology that are useful for interpreting atmospheric data. L. Mark Berliner is Professor of Statistics at Ohio State University.
Learn to use options from veteran option trader Mark D. Wolfinger, who spent more than 20 years on the floor of the Chicago Board Options Exchange (CBOE). If you are a seasoned stock trader or a casual investor who dabbles in mutual funds, this book is for you.
Iron condor trading has a lot to recommend it because the strategy is easy to understand and the trade can be set up with a high probability of making money. Those are very enticing qualities for traders, especially rookie traders. In Trading CTM (Close to the Money) Options, Wolfinger explains why better results are achieved by trading closer-to-the-money (CTM) iron condors. Discover why it’s actually advantageous to trade with a reduced probability of winning. The combination of larger profits (and smaller losses), coupled with the ease of making risk-reducing adjustments (if needed) make CTM iron condors the winning choice. Read the clear arguments why CTM iron condors come with a built-in trading advantage. Important reminder: No strategy is suitable under all market conditions.
In an era where "buy and hold" investment strategies no longer work, investors desperately need portfolio protection. Fortunately, it's available--in the form of options. In Why Trade Options? top trader and options instructor Mark D. Wolfinger shows how options can be used conservatively, to systematically reduce risk and protect assets. Wolfinger explains the choices that options provide to cautious investors and explains the tradeoffs associated with each alternative. You'll learn how to use "protective" (a.k.a. "married") puts to buy complete protection at a higher price--and how to use covered calls to gain more modest protection, without paying a dime out of pocket. Wolfinger shows how to use simple "collars" to gain more protection at lower cost and helps you use options-based "stock replacement" strategies to lock in stock profits (while objectively considering the tax implications). Nowadays, intelligent investors need to address risk as much as return. Why Trade Options? gives them powerful tools for doing just that.
This will help us customize your experience to showcase the most relevant content to your age group
Please select from below
Login
Not registered?
Sign up
Already registered?
Success – Your message will goes here
We'd love to hear from you!
Thank you for visiting our website. Would you like to provide feedback on how we could improve your experience?
This site does not use any third party cookies with one exception — it uses cookies from Google to deliver its services and to analyze traffic.Learn More.